Our Heritage

Our Heritage

QHBIO's
Technology-Driven Journey

Founded in 2021, QHBIO has grown on a strong foundation of medical device manufacturing and distribution. Driven by proprietary technologies and a deep understanding of evolving market trends, the company has continuously expanded its portfolio of medical devices, including skin boosters and fillers such as WELLSTOX Aqua Pro. Building on this momentum, QHBIO recently launched its cosmetics brand, WELLSTOX, further broadening its business scope and reinforcing its vision of becoming a leading global total aesthetic solutions provider.

QHBIO's Technology-Driven Journey

history 연혁

2025-2026

Product Launches & Domestic Distributor Network

  • Launched WELLSTOX Aqua Pro Lidocaine skin booster
  • Launched WELLSTOX ECM Ampoule home-care cosmetic
  • Exclusive distribution agreement signed for Wellstox Aqua Pro in Korea and Japan

2024

Product Launches & Domestic Distribution

  • Exclusive distribution agreement signed for ARTLINE and WELLSTOX in Poland
  • Supply agreement signed for cosmetic raw materials in Brazil
  • Filed for filler regulatory approval and signed distribution agreement in Iraq

2023

Year of Global Distribution Expansion

  • Exclusive distribution agreement signed for TIRAMER filler in Greece, Poland, Iran, and the UK
  • Supply agreement signed for WELLSTOX in Japan, Türkiye
  • Achieved the "USD 5 Million Export Tower" award at the 60th Trade Day (Presidential Citation, USD 6,649,772 / approx. KRW 9 billion)

2022

Patent Filings & First Overseas Exclusive Contracts

  • Patent filed: Hyaluronic acid-based dermal filler composition,
    Cross-linked hyaluronic acid-based dermal filler composition
  • Exclusive distribution agreement signed for TIRAMER filler in Türkiye & UAE
  • In-house R&D institute established

2021

Founding & First Export

  • QH BIo founded (May)
  • WELLSTOX ARTLINE TIRAMER brand launched
  • 1ˢᵗ export overseas